Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
62 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BIOTECH ENGINEERING from Gent, company number BE0460320725, closed financial year 2025 with a result of € 242,696 after tax. For that financial year BIOTECH ENGINEERING recorded a gross margin of € 419,085 and equity of € 418,727. Compared with financial year 2024, the result moved from € 1,058 to € 242,696. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2025.
€ 418,727
▲ 94% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 242,696
▲ € 241,638 vs 2024
Profit after tax over the fiscal year.
€ 516,297
▲ 41% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
16 % of the profit went to the shareholders, mostly to BIOTECH-INVEST (75 % of the shares). That is where the money ends up.
People and assets in 2025
€ 77,471
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,994
▼ 67% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 80,159
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 45,804
▲ 69% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 113,177 | € 110,356 | € 114,149 | € 419,085 | ▲ 267% |
| Profit after taxes | € 28,167 | € 285 | € 1,058 | € 242,696 | ▲ € 241,638 |
| Equity | € 564,688 | € 214,974 | € 216,032 | € 418,727 | ▲ 94% |
| Total debts | € 248,292 | € 262,010 | € 335,353 | € 368,887 | ▲ 10% |
| Cash | € 540,306 | € 353,735 | € 366,494 | € 516,297 | ▲ 41% |
| Land & buildings | € 65,096 | € 50,485 | € 36,660 | € 22,836 | ▼ 38% |
| Retained profit | € 515,083 | € 165,368 | € 166,426 | € 369,122 | ▲ 122% |
| Dividend | € 10,000 | € 350,000 | € 0 | € 40,000 | |
| Balance sheet total | € 812,981 | € 476,983 | € 551,384 | € 787,615 | ▲ 43% |
| Employees (FTE) | 1 | - | - | - |
Key figures of BIOTECH ENGINEERING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to BIOTECH ENGINEERING?
What happened at BIOTECH ENGINEERING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 242,696 (▲ € 241,638 vs 2024). Source: NBB ↗
- Biotech-Invest SRL became a director. NBB
- New establishment in Tournai. KBO
- Start of the company according to the CBE. KBO
In short
From € 28,167 profit in 2022 to € 242,696 profit in 2025.
Paid € 90,740 in corporate taxes since 2022.
Best year ever: 2025, with € 242,696 profit.
On average € 113,200 of value added per employee in 2022.
A new publication or filing at BIOTECH ENGINEERING? We notify you, reason included.
Follow BIOTECH ENGINEERINGDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of BIOTECH-INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BIOTECH ENGINEERINGBehind BIOTECH ENGINEERING are Biotech-Invest SRL and STEFAAN HEYVAERTS. The shares are held by BIOTECH-INVEST (75%).
Directors
According to the 2025 annual accounts
Director · represented by Katleen Lammens
since 2018
Shareholders
75%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Amelia Earhartlaan 2 box 304
9051 Gent
Rue de la Grande Couture(MAR) 2
7522 Tournai
Active since 1 April 1997
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 62 companies are registered at this address.
All companies at this address →UPGRADE ESTATE GROUP
€ 3 million gross margin · 2025
WESTATE
€ 40,264 gross margin · 2025
Timi UpKot
€ 643,357 gross margin · 2025
10 Upkot
€ 289,659 gross margin · 2025
Gandia
€ 43,171 gross margin · 2025
+57 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
INFOMANIAK-AS, CH
Website info
Features
Security
Network
Details
- Company number
- 0460.320.725
- VAT number
- BE 0460.320.725
- Registered office
- Amelia Earhartlaan 2 bus 304, 9051 Gent
- Names & denominations
- BIOTECH ENGINEERING · BTE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 March 1997
- Peppol
- Active · Active since 7 Apr 2026
- Contact
- biotech-engineering.be
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts